ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Monitoring"

  • 2022 American Transplant Congress

    The Effect of Baseline Blood Pressure on Early Graft Function in Deceased Donor Kidney Transplantation

    B. Jun Bae1, C. Oh1, H. Ahn2

    1Department of surgery, Ajou University Medical School, Suwon, Korea, Republic of, 2Department of Anesthesiology and Pain medicine, Ajou University Medical School, Suwon, Korea, Republic of

    *Purpose: The adequate perfusion pressure to the graft is essential for proper graft function in kidney transplantation, especially in deceased donor kidney transplantation. Therefore, the…
  • 2022 American Transplant Congress

    Measurement of Physical Activity and Frailty in the Early Post-Operative Period After Kidney Transplant-Single-Center Prospective Pilot Study Using Fitbit Watch

    T. Shamaa, L. Allenspach, O. Shamaa, S. Shimada, C. Crombez, O. Hage-Hassan, T. Kitajima, S. Yeddula, I. Bajjoka, L. Malinzak, J. Denny, D. Kim, M. Abouljoud, S. Nagai

    Henry Ford Transplant Institute, Detroit, MI

    *Purpose: Physical activity monitors (PAMs) allow patients to track multiple health parameters. PAM’s may be helpful to assess a patient’s physical recovery after a Kidney…
  • 2022 American Transplant Congress

    Utility of Donor Derived Cell-Free DNA in Liver Transplantation

    A. Zarrinpar, D. Lewis, C. Warren, S. Duarte

    Surgery, University of Florida, Gainesville, FL

    *Purpose: As a non-invasive measure of allograft injury, quantifying the fraction of donor-derived cell-free DNA (dd-cfDNA) has proven to be useful technique in kidney transplantation.…
  • 2022 American Transplant Congress

    Early Experience with OmniGraf® Biomarker Surveillance in Kidney Transplant Patients in the First-Year Post-Transplant and Beyond

    V. Paramasivam1, W. Ally2, B. Sivakumar3, B. Greco1, M. Germain1

    1Baystate Medical Center, Springfield, MA, 2Eurofins Transplant Genomics, Framingham, MA, 3Dartmouth College, Hanover, NH

    *Purpose: Non-invasive rejection biomarkers continue to evolve with recent data supporting the use of combined gene expression and donor derived cell-free DNA (dd-cfDNA) in kidney…
  • 2022 American Transplant Congress

    Clinical Stratification of Pediatric Liver Transplant Recipients 4-5 Years Post-Transplant: 1St Step Towards Personalized Management

    W. Dixon1, E. R. Perito1, M. Tavakol1, J. Bucuvalas2, S. Feng1

    1University of California, San Francisco, San Francisco, CA, 2Mount Sinai Kravis Children's Hospital and Recanati/Miller Transplantation Institute, Mount Sinai Health System, New York, NY

    *Purpose: Recent surveillance biopsy studies strongly associate high normal ALT (>35U/L) with inflammatory histopathology and low normal ALT (15yrs (n=13; p=0.0006), chronic rejection (CR) diagnosis…
  • 2022 American Transplant Congress

    A Novel, High Throughput Droplet Digital PCR-Based Indel Quantification Method for the Detection of Circulating Donor-Derived Cell-Free DNA After Kidney Transplantation

    J. G. Verhoeven1, K. Boer1, A. M. Peeters1, M. C. Clahsen-van Groningen2, J. I. Roodnat1, J. van de Wetering1, D. Nieboer3, D. A. Bost4, C. C. Baan1, D. A. Hesselink1

    1Department of Internal Medicine, Erasmus MC Transplant Institute, Rotterdam, Netherlands, 2Department of Pathology, University Medical Center Rotterdam, Rotterdam, Netherlands, 3Department of Public Health, University Medical Center Rotterdam, Rotterdam, Netherlands, 4JETA Molecular, Utrecht, Netherlands

    *Purpose: Donor-derived cell-free DNA (ddcfDNA) is a promising minimally invasive biomarker for acute rejection (AR) in kidney transplant recipients. To assess the diagnostic value of…
  • 2022 American Transplant Congress

    Single-Cell CyTOF Profiling of Pediatric Immune Responses to Organ Transplantation Reveals a Novel Subpopulation of T Cells Significantly Correlating with Graft Health

    M. Rao1, M. Amouzgar1, J. T. Harden1, M. Lapasaran1, A. Trickey1, B. Armstrong2, J. Odim3, T. Debnam3, C. Esquivel1, S. C. Bendall1, O. Martinez1, S. M. Krams1

    1Stanford University, Palo Alto, CA, 2Rho, Durham, NC, 3National Institutes of Health, Bethesda, MD

    *Purpose: Solid organ transplant is lifesaving for children with end-stage heart, liver, or kidney disease. Protection of the transplanted organ from rejection requires long-standing immunosuppression.…
  • 2022 American Transplant Congress

    Removing DSA and Region from Organ Allocation

    R. R. Goff1, A. R. Wilk1, J. Foutz1, A. Robinson1, S. E. Booker1, K. Bradbrook1, T. Mupfudze1, N. Turgeon2, M. Cooper3, D. Klassen1

    1United Network for Organ Sharing, Richmond, VA, 2University of Texas at Austin, Austin, TX, 3Medstar Georgetown, Washington , D.C., DC

    *Purpose: Over the past 4 years, the OPTN has removed Donation Service Area (DSA) and OPTN Region from deceased donor organ allocation with the goal…
  • 2022 American Transplant Congress

    Urine-based Assay For Detection Of Acute Rejection In Pediatric Kidney Transplant Recipients

    C. Crane1, K. Zeeb2, E. Phebus2, C. Benavides2, W. Wong3, E. Ingulli2

    1UCSD/Rady Children's Hospital, San Diego, CA, 2UCSD Rady Children's Hospital, San Diego, CA, 3Massachusetts General Brigham, Boston, MA

    *Purpose: Biomarkers such as donor-derived cell free DNA (cfDNA) and gene expression profiling are utilized in adult transplant patients (pts), but these tests lack sensitivity…
  • 2022 American Transplant Congress

    Absolute Quantification of Donor-Derived Cell-Free DNA Does Not Provide Additional Discriminating Power Over Donor-derived Cell-Free DNA Fraction for Detection of Allograft Rejection

    R. Gohh1, S. Jordan2, R. N. Woodward3, K. M. Clark-Langone3, J. Morlan3, B. Silva3, M. Weir4

    1Alpert School of Medicine Brown University, Providence, RI, 2Cedars Sinai Medical Ctr, Los Angeles, CA, 3CareDx, Redwood City, CA, 4University of Maryland School of Medicine, Baltimore, MD

    *Purpose: High level of background cell-free DNA (cfDNA) has been hypothesized as a concern for false negative results in molecular diagnostics for allograft rejection that…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • …
  • 22
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences